Frontlight ResearchEarly access
Trial site
Centro de Investigaciones Clinicas Vina Del Mar
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)4 trials
- Lung cancer3 trials
- Liver cirrhosis2 trials
- Multiple myeloma2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- and 9 more
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Regeneron Pharmaceuticals2 trials
- Contineum Therapeutics1 trial
- Daiichi Sankyo1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver cirrhosis1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Recruiting
Terminated
Completed
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026